blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1401839

EP1401839 - ANTIDEPRESSANT (SSSRI) AZAHETEROCYCLYMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-T,9-DIOXA-1,3-DIAZACYCLOPENTA [A] NAPHTHALENE [Right-click to bookmark this link]
Former [2004/14]ANTIDEPRESSANT (SSSRI) AZAHETEROCYCLYMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-T,9-DIOXA-1,3-DIAZACYCLOPENTA A]NAPHTHALENE
[2005/17]
StatusNo opposition filed within time limit
Status updated on  14.07.2006
Database last updated on 20.05.2024
Most recent event   Tooltip25.12.2009Lapse of the patent in a contracting state
New state(s): TR
published on 27.01.2010  [2010/04]
Applicant(s)For all designated states
Wyeth
Five Giralda Farms
Madison, NJ 07940-0874 / US
[N/P]
Former [2004/14]For all designated states
Wyeth
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Inventor(s)01 / STACK, Gary, Paul
525 Brookfield Road
Ambler, PA 19002 / US
 [2004/14]
Representative(s)Wileman, David Francis, et al
Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead
Berkshire SL6 OPH / GB
[N/P]
Former [2004/14]Wileman, David Francis Dr., et al
Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow
Maidenhead, Berkshire SL6 OPH / GB
Application number, filing date02728968.523.04.2002
[2004/14]
WO2002US12993
Priority number, dateUS20010286579P26.04.2001         Original published format: US 286579 P
[2004/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02088131
Date:07.11.2002
Language:EN
[2002/45]
Type: A1 Application with search report 
No.:EP1401839
Date:31.03.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 07.11.2002 takes the place of the publication of the European patent application.
[2004/14]
Type: B1 Patent specification 
No.:EP1401839
Date:07.09.2005
Language:EN
[2005/36]
Type: B9 Corrected patent specification 
No.:EP1401839
Date:30.11.2005
[2005/48]
Search report(s)International search report - published on:EP07.11.2002
ClassificationIPC:C07D491/04, C07D491/056, A61K31/41, A61K31/357, A61K31/445, A61P25/24
[2004/14]
CPC:
C07D491/04 (EP,US); A61P15/10 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/32 (EP);
A61P3/04 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/14]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ANTIDEPRESSIVE (SSSRI) AZAHETEROCYCLYLMETHYLDERIVATE VON 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZACYCLOPENTA [A] NAPHTHALIN[2005/17]
English:ANTIDEPRESSANT (SSSRI) AZAHETEROCYCLYMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-T,9-DIOXA-1,3-DIAZACYCLOPENTA [A] NAPHTHALENE[2005/17]
French:L'AZAHETEROCYCLYMETHYLE (SSSRI), ANTIDEPRESSEUR DERIVANT DU 7,8-DIHYDRO-3H-T,9-DIOXA-1,3-DIAZACYCLOPENTA [A] NAPHTHALENE[2005/17]
Former [2004/14]ANTIDEPRESSIVE (SSSRI) AZAHETEROCYCLYLMETHYLDERIVATE VON 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZACYCLOPENTAçA!NAPHTHALIN
Former [2004/14]ANTIDEPRESSANT (SSSRI) AZAHETEROCYCLYMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-T,9-DIOXA-1,3-DIAZACYCLOPENTA A]NAPHTHALENE
Former [2004/14]L'AZAHETEROCYCLYMETHYLE (SSSRI), ANTIDEPRESSEUR DERIVANT DU 7,8-DIHYDRO-3H-T,9-DIOXA-1,3-DIAZACYCLOPENTA A]NAPHTHALENE
Entry into regional phase13.10.2003National basic fee paid 
13.10.2003Designation fee(s) paid 
13.10.2003Examination fee paid 
Examination procedure14.11.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.10.2003Amendment by applicant (claims and/or description)
13.10.2003Examination requested  [2004/14]
16.04.2004Despatch of a communication from the examining division (Time limit: M06)
19.10.2004Reply to a communication from the examining division
24.03.2005Communication of intention to grant the patent
13.07.2005Fee for grant paid
13.07.2005Fee for publishing/printing paid
Opposition(s)08.06.2006No opposition filed within time limit [2006/33]
Fees paidRenewal fee
06.04.2004Renewal fee patent year 03
04.04.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.04.2006
CY23.04.2006
TR23.04.2006
BE30.04.2006
MC30.04.2006
[2010/04]
Former [2007/46]AT23.04.2006
CY23.04.2006
BE30.04.2006
MC30.04.2006
Former [2007/28]CY23.04.2006
BE30.04.2006
MC30.04.2006
Former [2007/14]CY23.04.2006
MC30.04.2006
Former [2007/07]MC30.04.2006
Cited inInternational search[Y]WO9113872  (UPJOHN CO [US]) [Y] 1-32 * see the definition of A,B = O and X = b) *; column W *;
 [Y]EP0771800  (AMERICAN HOME PROD [US]) [Y] 1-32 * see the definiton of Z *; column W *;
 [Y]WO9723485  (KNOLL AG [DE], et al) [Y] 1-32 * see the definition of G1,G2,Ge and T *; column W *;
 [Y]WO9816530  (AMERICAN HOME PROD [US]) [Y] 1-32 * see the defintiton of R3, R4 *; column W *;
 [Y]WO9829415  (KNOLL AG [DE], et al) [Y] 1-32 * see claim 1, definition of G1,G2,G3 *; column W *;
 [Y]WO9840386  (KNOLL AG [DE], et al) [Y] 1-32 * see the definition of G1,G2,Ge and T *; column W *;
 [Y]US5869490  (STACK GARY PAUL [US]) [Y] 1-32* see the definition of Z and R2 *; column W *;
 [Y]  - ENNIS M D ET AL, "NOVEL INDOLODIOXANES WITH ANTIHYPERTENSIVE EFFECTS: POTENT LIGANDS FOR THE 5-HT1A RECEPTOR", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19920807), vol. 35, no. 16, ISSN 0022-2623, pages 3058 - 3066, XP000608326 [Y] 1-32 * see p.3060, table 1, exs. 22, 23 *; column W *

DOI:   http://dx.doi.org/10.1021/jm00094a021
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.